Literature DB >> 21518940

Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Adeel A Butt1, Chung-Chou Chang, Lewis Kuller, Matthew Bidwell Goetz, David Leaf, David Rimland, Cynthia L Gibert, Krisann K Oursler, Maria C Rodriguez-Barradas, Joseph Lim, Lewis E Kazis, Stephen Gottlieb, Amy C Justice, Matthew S Freiberg.   

Abstract

BACKGROUND: Whether human immunodeficiency virus (HIV) infection is a risk factor for heart failure (HF) is not clear. The presence of coronary heart disease and alcohol consumption in this population may confound this association.
METHODS: To determine whether HIV infection is a risk factor for incident HF, we conducted a population-based, retrospective cohort study of HIV-infected and HIV-uninfected veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC) and the 1999 Large Health Study of Veteran Enrollees (LHS) from January 1, 2000, to July 31, 2007.
RESULTS: There were 8486 participants (28.2% HIV-infected) enrolled in the VACS-VC who also participated in the 1999 LHS. During the median 7.3 years of follow-up, 286 incident HF events occurred. Age- and race/ethnicity-adjusted HF rates among HIV-infected and HIV-uninfected veterans were 7.12 (95% confidence interval [CI], 6.90-7.34) and 4.82 (95% CI, 4.72-4.91) per 1000 person-years, respectively. Compared with HIV-uninfected veterans, those who were HIV infected had an increased risk of HF (adjusted hazard ratio [HR], 1.81; 95% CI, 1.39-2.36). This association persisted among veterans who did not have a coronary heart disease event or a diagnosis related to alcohol abuse or dependence before the incident HF event (adjusted HR, 1.96; 95% CI, 1.29-2.98). Compared with HIV-uninfected veterans, those who were HIV infected with a baseline Human immunodeficiency virus 1 (HIV-1) RNA level of 500 or more copies/mL had a higher risk of HF (adjusted HR, 2.28; 95% CI, 1.57-3.32), while those with baseline and a recent HIV-1 RNA level less than 500 copies/mL did not (adjusted HR, 1.10; 95% CI,  0.64-1.89; P < .001 for comparison between high and low HIV-1 RNA groups).
CONCLUSIONS: Our data suggest that HIV infection is a risk factor for HF. Ongoing viral replication is associated with a higher risk of developing HF.

Entities:  

Mesh:

Year:  2011        PMID: 21518940      PMCID: PMC3687533          DOI: 10.1001/archinternmed.2011.151

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  36 in total

1.  Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome.

Authors:  D W Anderson; R Virmani; J M Reilly; T O'Leary; R E Cunnion; M Robinowitz; A M Macher; U Punja; S T Villaflor; J E Parrillo
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

2.  Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.

Authors:  Stacy D Fisher; Kirk A Easley; E John Orav; Steven D Colan; Samuel Kaplan; Thomas J Starc; J Timothy Bricker; Wyman W Lai; Douglas S Moodie; George Sopko; Steven E Lipshultz
Journal:  Am Heart J       Date:  2005-09       Impact factor: 4.749

3.  Coronary heart disease in HIV-infected individuals.

Authors:  Judith S Currier; Anne Taylor; Felicity Boyd; Christopher M Dezii; Hugh Kawabata; Beth Burtcel; Jen-Fue Maa; Sally Hodder
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

4.  Impact of HIV infection on diastolic function and left ventricular mass.

Authors:  Priscilla Y Hsue; Peter W Hunt; Jennifer E Ho; Husam H Farah; Amanda Schnell; Rebecca Hoh; Jeffrey N Martin; Steven G Deeks; Ann F Bolger
Journal:  Circ Heart Fail       Date:  2009-11-20       Impact factor: 8.790

Review 5.  Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era.

Authors:  Daniel Vittecoq; Lelia Escaut; Gilles Chironi; Elina Teicher; Jean Jacques Monsuez; Michel Andrejak; Alain Simon
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

Review 6.  Immunopathogenesis of HIV-related heart muscle disease: current perspectives.

Authors:  Peter F Currie; Nicholas A Boon
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

7.  Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.

Authors:  Adeel A Butt; Shawn L Fultz; C Kent Kwoh; David Kelley; Melissa Skanderson; Amy C Justice
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

8.  Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome.

Authors:  J M Reilly; R E Cunnion; D W Anderson; T J O'Leary; J T Simmons; H C Lane; A S Fauci; W C Roberts; R Virmani; J E Parrillo
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

9.  An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy.

Authors:  Giuseppe Barbaro; Gabriella Di Lorenzo; Augusto Cirelli; Benvenuto Grisorio; Alfio Lucchini; Christine Hazra; Giorgio Barbarini
Journal:  Clin Ther       Date:  2003-09       Impact factor: 3.393

10.  Mitochondrial myopathy caused by long-term zidovudine therapy.

Authors:  M C Dalakas; I Illa; G H Pezeshkpour; J P Laukaitis; B Cohen; J L Griffin
Journal:  N Engl J Med       Date:  1990-04-19       Impact factor: 91.245

View more
  101 in total

1.  Preventing Heart Failure in Inflammatory and Immune Disorders.

Authors:  Maya Serhal; Chris T Longenecker
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-06

Review 2.  Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation.

Authors:  Avanthi Raghavan; Dodie E Rimmelin; Kathleen V Fitch; Markella V Zanni
Journal:  Curr HIV/AIDS Rep       Date:  2017-12       Impact factor: 5.071

Review 3.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 4.  Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.

Authors:  Arjun Sinha; Matthew Feinstein
Journal:  Prog Cardiovasc Dis       Date:  2020-01-24       Impact factor: 8.194

5.  Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research.

Authors:  Homer L Twigg; Ronald Crystal; Judith Currier; Paul Ridker; Nancy Berliner; Hans-Peter Kiem; George Rutherford; Shimian Zou; Simone Glynn; Renee Wong; Emmanuel Peprah; Michael Engelgau; Tony Creazzo; Sandra Colombini-Hatch; Elisabet Caler
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

Review 6.  HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.

Authors:  Revery P Barnes; John Charles A Lacson; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

7.  Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV.

Authors:  William C Becker; Kirsha Gordon; E Jennifer Edelman; Robert D Kerns; Stephen Crystal; James D Dziura; Lynn E Fiellin; Adam J Gordon; Joseph L Goulet; Amy C Justice; David A Fiellin
Journal:  AIDS Behav       Date:  2016-03

8.  Inflammation and Fibrosis in HIV: Getting to the Heart of the Matter.

Authors:  Priscilla Y Hsue; Ahmed Tawakol
Journal:  Circ Cardiovasc Imaging       Date:  2016-03       Impact factor: 7.792

9.  Trends in Cardiovascular Disease Mortality Among Persons With HIV in New York City, 2001-2012.

Authors:  David B Hanna; Chitra Ramaswamy; Robert C Kaplan; Jorge R Kizer; Kathryn Anastos; Demetre Daskalakis; Regina Zimmerman; Sarah L Braunstein
Journal:  Clin Infect Dis       Date:  2016-07-20       Impact factor: 9.079

Review 10.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.